China biotech deals hit record as innovative drugs draw interest of multinationals
--------------------------------------------------------------------
Source: South China Morning Post
Published: 2026-03-29 22:26 UTC+10:00
Section: drug outlicensing deals
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Asia, China, Drugs, Business & Economy, Asia Pacific
--------------------------------------------------------------------
Snippet:
Deals reach US$60 billion in first quarter after analysts say Chinese biotech firms have shown substantial technological advancements
--------------------------------------------------------------------